Alvotech FDA Approval Clears Path To Challenge Humira

Simlandi Is First US Interchangeable Citrate-Free High-Concentration Adalimumab Biosimilar

 
• By David Wallace
  
Red wooden figure in front of crowd
Alvotech believes it can stand out among Humira biosimilars • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products